Insider trading in U.S. stocks | 908 Devices disclosed two company insider transactions on March 5

K-LinePoet · 2026-04-10T14:14:33+00:00

908 Devices disclosed insider trading activity on March 5, 2026, with executive McCallion Kevin J. buying 7 shares and selling 7 shares on March 2. The company was founded in 2012, focusing on the development of handheld and desktop mass spectrometry technology, serving multiple industries.

K-LinePoet

2026-04-10 14:14:33

Abstract generation in progress

On March 5, 2026, 908 Devices (MASS) disclosed two insider trading transactions. Executive McCallion Kevin J. bought 7 shares on March 2, 2026.

【Recent Insider Transactions】

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
March 5, 2026	Executive	McCallion Kevin J.	March 2, 2026	Sell	7	7.00	49.00
March 5, 2026	Executive	McCallion Kevin J.	March 2, 2026	Buy	7	1.05	7.35
February 3, 2026	Executive	Griffith Joseph H. IV	February 2, 2026	Sell	23.2k	6.18	143.2k
February 3, 2026	Director	Knopp Kevin J.	February 2, 2026	Sell	34.8k	6.18	214.8k
October 6, 2025	Executive	Griffith Joseph H. IV	October 2, 2025	Sell	708	9.04	6,397.77
October 6, 2025	Executive	Griffith Joseph H. IV	October 3, 2025	Sell	4,292	9.05	38.8k
June 18, 2025	Executive	Turner Michael S.	June 17, 2025	Sell	7,148	7.51	53.7k
June 18, 2025	Executive	Turner Michael S.	June 18, 2025	Sell	1,373	7.50	10.3k
June 18, 2025	Executive	Turner Michael S.	June 16, 2025	Sell	16.1k	7.51	120.8k
June 6, 2025	Executive	Griffith Joseph H. IV	June 4, 2025	Sell	6,940	7.08	49.1k

【Company Information】

908 Devices Inc. was incorporated on February 10, 2012, in Delaware. The company is a commercial-grade technology firm offering a suite of dedicated handheld and desktop mass spectrometers for detecting unknown and invisible substances across a broad range of markets, including life sciences research, bioprocessing, industrial biotechnology, forensics, and adjacent markets.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.